Degradable and Bioadhesive Alginate-Based Composites: An Effective Hemostatic Agent
He Huang1,2, Hongsai Chen1, Xueling Wang1
1Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases, Shanghai 200125, China.
ACS Biomaterials Science & Engineering
|January 19, 2021
Summary
A new composite material, SACC, effectively stops bleeding from organs and vessels. This biodegradable and biocompatible hemostatic agent shows great promise for clinical use.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Surgical Innovation
Background:
- Effective hemostasis is critical for managing severe hemorrhaging.
- Ideal hemostatic agents require rapid action, biodegradability, biocompatibility, ease of application, and affordability.
Purpose of the Study:
- To synthesize and evaluate a novel degradable powdery hemostatic composite (SACC) using sodium alginate (SA), carboxymethyl chitosan (CMC), and collagen.
- To assess the hemostatic efficacy, biocompatibility, and biodegradability of SACC.
Main Methods:
- SACC was synthesized via emulsification and cross-linking.
- Material characterization included Fourier transform infrared spectroscopy and scanning electron microscopy (SEM).
- Hemostatic efficacy was tested using in vitro and in vivo bleeding models (rat liver injury and tail amputation).
- Cytocompatibility, biocompatibility, and biodegradability were evaluated through cytotoxicity tests, SEM, histomorphological analysis, and immunofluorescence.
Main Results:
- SACC exhibited a spherical morphology with a narrow size distribution, rough surface, and good water absorption.
- SACC demonstrated superior hemostatic actions compared to CMC and SA in both in vitro and in vivo models.
- Cytotoxicity tests and SEM confirmed excellent cytocompatibility.
- Histomorphological evaluation indicated superior biocompatibility during wound healing.
- In vitro and in vivo immunofluorescence confirmed the biodegradability of SACC.
Conclusions:
- The synthesized SACC composite possesses excellent hemostatic activity.
- SACC exhibits favorable biodegradability and biocompatibility properties.
- SACC shows significant potential for clinical applications in hemostasis.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Introduction to Hemostasis
11.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
11.8K


